Please assess the completion status of the following clinical trial:

Trial Title: Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Ability to undergo endoscopy with required biopsy~* Ages 1 through 5 years~* Endoscopically confirmed GERD by positive endoscopic evidence of reflux related esophagitis or positive histologic evidence of esophagitis consistent with GERD Other inclusions apply.~Exclusion Criteria:~* History or presence of upper gastrointestinal anatomic or motor disorders~* Known current or active cow's milk allergy~* Malignancy~* Other exclusions apply.

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 5 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Arm 1- Low Dose pantoprazole
- 2 (Type: ACTIVE_COMPARATOR): Arm 2- Medium Dose pantoprazole
- 3 (Type: ACTIVE_COMPARATOR): Arm 3- High Dose pantoprazole

Based on this trial design, predict the completion outcome and termination type (if applicable).